NLRP3 and Parkinson disease: NLRP3 and ASC have been shown to be upregulated in substantia nigra microglia of PD patients and have also been detected in the striatal microglia of mouse models of parkinsonism14, implicating the NLRP3 inflammasome as a key agent in PD pathology.